Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma.

Gabrielle Cote,Husam Alqaisi,Christopher T Chan,Di Maria Jiang, Christopher Kandel,Karyne Pelletier,Ron Wald,Srikala S Sridhar,Abhijat Kitchlu

Kidney360（2023）

引用 1|浏览13

暂无评分

摘要

s: There was no significant difference in the incidence of AKI between the three regimens studied. However, standard gem-cis was associated with improved cancer outcomes. Novel regimens and kidney protective strategies are needed for mUC patients with kidney disease.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要